Last reviewed · How we verify
Reference standard
At a glance
| Generic name | Reference standard |
|---|---|
| Also known as | Tuberculin PPD Standard., US Reference Standard |
| Sponsor | JHP Pharmaceuticals LLC |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
- Er,Cr:YSGG Laser Versus Conventional Preparation for Minimally Invasive Caries Removal (NA)
- The Impact of Music Medicine on Preterm Brain Development and Behavior (NA)
- Serial Brain MRI in Hospitalized Preterm Infants (NA)
- Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes (NA)
- GNB4 and Riplet Gene Methylation Combined Detection Kit for Hepatocellular Carcinoma Recurrence Monitoring
- Non-apnea Saline-contrast EIT for Lung Perfusion Imaging in Spontaneously Breathing Patients: A Prospective Cross-over Study (NA)
- TES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Symptoms (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reference standard CI brief — competitive landscape report
- Reference standard updates RSS · CI watch RSS
- JHP Pharmaceuticals LLC portfolio CI